+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Transplantation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083581
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The transplantation market is undergoing significant transformation as organizations increasingly balance clinical innovation, regulatory scrutiny, and evolving supply-chain demands. Senior decision-makers now face more complex procurement and operational workflows, requiring a strategic approach to sustain competitiveness and drive improved patient outcomes. The sector's changing dynamics highlight the importance of technology integration and adaptive strategies to support reliable access and quality of care.

Market Snapshot: Transplantation Market Size and Growth

The transplantation market expanded from USD 11.87 billion in 2025 to USD 12.84 billion in 2026 and is projected to reach USD 21.99 billion by 2032, growing at a CAGR of 9.20%. This growth trajectory is supported by continued expansion in transplant programs and a parallel rise in demand for advanced devices, pharmaceutical products, and integrated care delivery solutions. Factors such as program scalability and innovation in care models are fostering sustained momentum across global regions.

Scope & Segmentation of the Transplantation Market

  • Organ Types: Coverage includes heart, intestine, kidney, liver, lung, and pancreas transplantation, each presenting distinct procedural complexities, equipment needs, and care models for stakeholders.
  • Product Types: Assessed categories encompass consumables like catheters and sutures, critical devices for monitoring and preservation, implants including artificial organs and vascular grafts, and key pharmaceutical classes such as mTOR inhibitors, corticosteroids, and antiproliferative agents.
  • Donor Types: Analysis differentiates between deceased and living donor pathways, with a focus on implications for preservation timelines, procedural logistics, and procurement management.
  • Procedure Types: Segments comprise laparoscopic, open, and robotic approaches, each affecting care pathways and influencing technology selection in clinical practice.
  • End Users: Insights extend to ambulatory surgical centers, hospitals, and specialty clinics, which demonstrate diverse purchasing routines, inventory considerations, and care delivery models.
  • Regions: The report provides intelligence on the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting how regional adoption, policy environments, and supply resilience differ, impacting market access and growth strategies.
  • Technologies: Evaluation includes advancements such as robotic and minimally invasive surgical tools, ex vivo organ perfusion, advanced preservation solutions, and comprehensive digital monitoring platforms.

Key Takeaways for Senior Decision-Makers

  • Informed strategies require synthesizing clinical innovation with real-world procurement and policy shifts to align operating models with fast-evolving sector demands.
  • Progress in preservation and minimally invasive surgery is broadening the availability of suitable donors and modifying clinical and equipment requirements across organ programs.
  • Collaboration between device, pharmaceutical, and healthcare service stakeholders is fostering integrated offerings, leading to more holistic and streamlined product solutions for institutions.
  • Digital platforms for real-time monitoring and data capture are improving patient follow-up and care coordination, supporting operational flexibility and shorter acute care episodes for providers.
  • Market access and commercial strategies benefit from recognizing regional regulatory and infrastructure disparities, enabling the development of tailored models for effective entry and sustained growth.
  • Clinician training programs and post-market data collection play a pivotal role in accelerating adoption, ensuring compliance, and supporting reimbursement outcomes across multiple healthcare settings.

Tariff Impact on Procurement and Supply Chain

Recent tariff adjustments have reshaped the economics and logistics of cross-border procurement within the transplantation value chain. These policy changes have increased costs for specialized medical devices, implants, and pharmaceuticals, prompting organizations to rethink supplier engagement and diversify sourcing channels. Investments in nearshoring and onshoring are becoming prevalent among both health systems and manufacturers to reduce delays and price volatility. Supplier agreements increasingly focus on risk management, with some smaller manufacturers exploring partnerships or consolidation to remain viable. Additionally, these tariff-driven pressures are spurring interest in technologies that enhance clinical throughput and operational efficiency, seeking to justify higher acquisition expenses with measurable performance gains.

Methodology & Data Sources

This analysis leverages interviews with clinical leaders, procurement and regulatory experts, and supply-chain specialists. Expert panels validate findings, complemented by secondary reviews of clinical literature, regulatory submissions, and relevant policy announcements. This triangulation ensures a balanced and actionable evidence base for decision-making.

Why This Report Matters for B2B Market Leaders

  • Equips senior executives to anticipate changes in clinical, operational, and regulatory landscapes, optimizing strategy within the transplant sector.
  • Delivers actionable guidance for investments in new technologies and supply-chain innovation, supporting organizational resilience and care improvement.
  • Empowers market participants with detailed segmentation and practical procurement intelligence to drive effective commercialization and real-world adoption.

Conclusion

Strategic adaptation in the transplantation market requires integrated solutions and organizational agility. Decision-makers who prioritize innovation, efficient sourcing, and responsive policy alignment are best positioned to elevate access and support improved patient care amid industry change.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Transplantation Market, by Organ Type
8.1. Heart
8.2. Intestine
8.3. Kidney
8.4. Liver
8.5. Lung
8.6. Pancreas
9. Transplantation Market, by Product Type
9.1. Consumables
9.1.1. Catheters
9.1.2. Grafts
9.1.3. Sutures
9.2. Devices
9.2.1. Monitoring Devices
9.2.2. Perfusion Devices
9.2.3. Preservation Solutions
9.3. Implants
9.3.1. Artificial Organs
9.3.2. Vascular Grafts
9.4. Pharmaceuticals
9.4.1. Antiproliferative Agents
9.4.2. Calcineurin Inhibitors
9.4.3. Corticosteroids
9.4.4. Mtor Inhibitors
10. Transplantation Market, by Donor Type
10.1. Deceased Donor
10.2. Living Donor
11. Transplantation Market, by Procedure Type
11.1. Laparoscopic
11.2. Open
11.3. Robotic
12. Transplantation Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Specialty Clinics
13. Transplantation Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Transplantation Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Transplantation Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Transplantation Market
17. China Transplantation Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 21st Century Medicine
18.6. AbbVie Inc.
18.7. Astellas Pharma Inc.
18.8. Baxter International Inc.
18.9. Bio-Rad Laboratories, Inc.
18.10. BiolifeSolutions, Inc.
18.11. Bristol-Myers Squibb Company
18.12. CHIESI Farmaceutici S.p.A.
18.13. Dr. Franz Kohler Chemie GmbH
18.14. F. Hoffmann-La Roche AG
18.15. Illumina, Inc.
18.16. Johnson & Johnson
18.17. Medtronic PLC
18.18. Merck KGaA
18.19. Novartis AG
18.20. Organ Recovery Systems, Inc.
18.21. Organovo, Inc.
18.22. OrganOx Limited
18.23. Pfizer Inc.
18.24. Plexision, Inc.
18.25. Sanofi S.A.
18.26. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEART, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEART, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEART, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY INTESTINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY INTESTINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY INTESTINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY KIDNEY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY KIDNEY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY KIDNEY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSPLANTATION MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSPLANTATION MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TRANSPLANTATION MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TRANSPLANTATION MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSPLANTATION MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TRANSPLANTATION MARKET SIZE, BY GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSPLANTATION MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TRANSPLANTATION MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TRANSPLANTATION MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TRANSPLANTATION MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSPLANTATION MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSPLANTATION MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TRANSPLANTATION MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TRANSPLANTATION MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TRANSPLANTATION MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSPLANTATION MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSPLANTATION MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TRANSPLANTATION MARKET SIZE, BY PERFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TRANSPLANTATION MARKET SIZE, BY PERFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSPLANTATION MARKET SIZE, BY PERFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSPLANTATION MARKET SIZE, BY ARTIFICIAL ORGANS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSPLANTATION MARKET SIZE, BY ARTIFICIAL ORGANS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSPLANTATION MARKET SIZE, BY ARTIFICIAL ORGANS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSPLANTATION MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TRANSPLANTATION MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TRANSPLANTATION MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TRANSPLANTATION MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TRANSPLANTATION MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TRANSPLANTATION MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TRANSPLANTATION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TRANSPLANTATION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TRANSPLANTATION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TRANSPLANTATION MARKET SIZE, BY MTOR INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TRANSPLANTATION MARKET SIZE, BY MTOR INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TRANSPLANTATION MARKET SIZE, BY MTOR INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVING DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVING DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TRANSPLANTATION MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TRANSPLANTATION MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TRANSPLANTATION MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TRANSPLANTATION MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TRANSPLANTATION MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TRANSPLANTATION MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TRANSPLANTATION MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TRANSPLANTATION MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TRANSPLANTATION MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TRANSPLANTATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TRANSPLANTATION MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TRANSPLANTATION MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS TRANSPLANTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 147. EUROPE TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. AFRICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 166. AFRICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 167. AFRICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 168. AFRICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. ASEAN TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 187. ASEAN TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 188. ASEAN TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 189. ASEAN TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 190. ASEAN TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASEAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GCC TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 195. GCC TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. GCC TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 197. GCC TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 198. GCC TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 199. GCC TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 200. GCC TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. BRICS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. BRICS TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 215. BRICS TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. BRICS TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 217. BRICS TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 218. BRICS TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 219. BRICS TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 220. BRICS TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 222. BRICS TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. G7 TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. G7 TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 225. G7 TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. G7 TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 227. G7 TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 228. G7 TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 229. G7 TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 230. G7 TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. NATO TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 235. NATO TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. NATO TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 237. NATO TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 238. NATO TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 239. NATO TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 240. NATO TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 242. NATO TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. CHINA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. CHINA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 256. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. CHINA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 258. CHINA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 259. CHINA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
TABLE 260. CHINA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 261. CHINA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Transplantation market report include:
  • 21st Century Medicine
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Baxter International Inc.
  • Bio-Rad Laboratories, Inc.
  • BiolifeSolutions, Inc.
  • Bristol-Myers Squibb Company
  • CHIESI Farmaceutici S.p.A.
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Organ Recovery Systems, Inc.
  • Organovo, Inc.
  • OrganOx Limited
  • Pfizer Inc.
  • Plexision, Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.

Table Information